Navigation Links
Cipla Offers Modest AIDS Drug Price Cut: 'Not Nearly Enough,' says AHF
Date:12/13/2007

NEW DELHI, Dec. 13 /PRNewswire-USNewswire/ -- As part of its ongoing global campaign to lower drug prices and improve access to lifesaving HIV/AIDS treatments in India and worldwide, AIDS Healthcare Foundation (AHF) today responded to a modest price cut recently offered in India by generic drug manufacturer, Cipla, on three of its antiretroviral drugs to fight HIV/AIDS. The cost reduction comes on the heels of an AHF-led advocacy campaign aimed at pressuring Cipla to lower its prices in India -- a campaign that revealed a price difference of 150% between what Cipla has offered African and Indian purchasers for the lifesaving antiretroviral combination Viraday.

"We applaud Cipla's recent price cut as a small step in the right direction. However, a price cut of 5% to 15% is nowhere near enough to make Cipla's lifesaving HIV/AIDS drugs affordable and accessible to all Indians in need," said Chinkholal Thangsing, M.D., Asia Pacific Bureau Chief for the AIDS Healthcare Foundation and a medical provider based in New Delhi. "We urge Cipla to make the dramatic price cuts necessary to ensure that its own countrymen and women will benefit from the company's ability to produce cheap medicines -- just as those in Africa and other parts of the developing world have benefited."

AHF has learned that Cipla's recent price reduction was offered as a gift from Cipla to all Indian patients on the occasion of World AIDS Day. Physicians have received communication regarding the new prices, which have been available since December 1st, World AIDS Day.

The following chart details the price reduction offered in both Indian rupees and US dollars:

Cipla Drug Old Price INR (US $) New Price INR (US $)

Viraday 54000 (US $1341) 46800 (US $1163)

Efavir 28308 (US $703) 24000 (US $596)

Tenvir-EM 25200 (US $626) 24000 (US $596)

"Of the 2.5 million people now estimated to be living with HIV/AIDS in India, only around 85,000 are receiving lifesaving antiretroviral treatment," said Dr. Mahesh Ganesan, Advocacy Coordinator for AIDS Healthcare Foundation. "If the average income is 29000 rupees -- which, according to the World Bank, is India's gross national income -- then whether a year's supply of medicines costs 54000 rupees a year or 46800 makes little difference, as it is still far too high and still beyond the reach of most Indians in need."

This past August, AHF and several Indian civil society partners and co- sponsors rolled out the drug pricing advocacy campaign with a print ad headlined, "Profit at What Cost? AIDS Drugs for All." The ad, which appeared in prominent Indian newspapers questioned Cipla regarding a price difference of 150% between what Cipla has offered African and Indian purchasers for the lifesaving antiretroviral combination Viraday. Cipla has yet to dispute the fact that it offers dramatically different prices to Africa than to its own fellow countrymen for this drug.

Because of questions raised by the drug-pricing advocacy campaign, Cipla is currently under investigation by the Monopolies and Restrictive Trade Practices Commission (MRTPC), India's anti-trust commission that probes monopolistic, restrictive and unfair trade practices, over its possible overpricing of Viraday.

AIDS Healthcare Foundation (AHF) operates free AIDS treatment clinics in India under AHF India Cares in Mysore, New Delhi and in Guwahati, Assam in collaboration with the National AIDS Control Organization (NACO). Additionally, in the Asia/Pacific region, AHF currently provides free antiretroviral treatment to people in need through its clinics in Thailand, Viet Nam, Cambodia and China.

AIDS Healthcare Foundation is the US' largest non-profit HIV/AIDS healthcare, research, prevention and education provider. AHF currently provides medical care and/or services to more than 61,000 individuals in 19 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at http://www.aidshealth.org


'/>"/>
SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
2. Health care incentive model offers collaborative approach
3. Eye-staining technique offers early detection for dry eye syndrome
4. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
5. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
6. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
7. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
8. Regence Offers InterM to Fill Gap for the Uninsured
9. Super Jake Foundation Offers Hope for Pediatric Cancer
10. Concentra Offers a Cure For What Ails You
11. National Non-Profit Organization Offers Free Mental Health Services to Military and Military Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... that the company will provide alerting technology to Central Illinois Health Information ... $1.7 million in federal funds as the sole sub-recipient participating with the ...
(Date:12/5/2016)... , ... December 05, 2016 , ... Dr. Barry M. ... Cosmetic Plastic Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium ... the newest techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is ...
(Date:12/5/2016)... ... December 05, 2016 , ... Florida Hospital has named Robin ... Region. McGuinness brings experience in executive leadership and clinical practice, as well as ... In her new role, that officially begins December 12, 2016, she will set ...
(Date:12/5/2016)... Franklin Lakes, NJ (PRWEB) , ... December 05, ... ... the recording studio teaming up on new songs with prolific Songwriter-Producer Corey “Chorus” ... Jamie Foxx, Kelly Rowland, Ciara, Brandy…just to name a few.     https://twitter.com/coreychorus ...
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves come ... buy neoprene knee sleeves for lifting and any sport that requires knee ... two main aspects to provide a higher quality knee sleeve performance. Firstly it is ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)...  Wellbridge Health and Gateway Health proudly announce a dynamic ... and Medicaid plan members with specific high risk needs. ... of this group of consumers, Wellbridge combines technology and population ... insight into members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... 2016 Eisai Inc. announced today new analyses ... Meeting of the American Epilepsy Society (AES). ... an adjunctive therapy for the treatment of partial onset ... primary generalized tonic-clonic seizures (PGTC) in patients with epilepsy ... see Important Safety Information for FYCOMPA, including Boxed WARNING ...
Breaking Medicine Technology: